menu
    • menu
    [{"orgOrder":0,"company":"4Life Research, LLC","sponsor":"Professional Athletic Orthopedics | St. Louis University","pharmaFlowCategory":"DU","therapeuticArea":"Rheumatology","country":"","productType":"Undisclosed","year":"2022","type":"Inapplicable","leadProduct":"Inapplicable","moa":"||Undisclosed","graph1":"Rheumatology","graph2":"Undisclosed","graph3":"4Life Research, LLC","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Rheumatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"4Life Research, LLC \/ Professional Athletic Orthopedics | St. Louis University","highestDevelopmentStatusID":"1","companyTruncated":"4Life Research, LLC \/ Professional Athletic Orthopedics | St. Louis University"},{"orgOrder":0,"company":"Amway (China) R&D Center","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Rheumatology","country":"","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"Inapplicable","moa":"||Undisclosed","graph1":"Rheumatology","graph2":"Undisclosed","graph3":"Amway (China) R&D Center","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Rheumatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Amway (China) R&D Center \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Amway (China) R&D Center \/ Inapplicable"}]

    Find Clinical Drug Development Pipelines & Deals | PipelineProspector

    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Amway (China) R&D Center

                            Country arrow
                            EPSC
                            Not Confirmed

                            Amway (China) R&D Center

                            Country arrow
                            EPSC
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Undisclosed,Inapplicable

                            Therapeutic Area : Rheumatology

                            Study Phase : Undisclosed

                            Sponsor : Inapplicable

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            The Efficacy of Amway Uric Acid Lowering Product on Hyperuricemia

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            October 16, 2023

                            Lead Product(s) : Undisclosed,Inapplicable

                            Therapeutic Area : Rheumatology

                            Highest Development Status : Undisclosed

                            Sponsor : Inapplicable

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            4Life Research, LLC

                            Country arrow
                            EPSC
                            Not Confirmed

                            4Life Research, LLC

                            Country arrow
                            EPSC
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Undisclosed,Inapplicable

                            Therapeutic Area : Rheumatology

                            Study Phase : Undisclosed

                            Sponsor : Professional Athletic Orthopedics | St. Louis University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Gold Factor on Knee Joint Health and Function

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            April 26, 2022

                            Lead Product(s) : Undisclosed,Inapplicable

                            Therapeutic Area : Rheumatology

                            Highest Development Status : Undisclosed

                            Sponsor : Professional Athletic Orthopedics | St. Louis University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Henning Bliddal

                            Country arrow
                            EPSC
                            Not Confirmed

                            Henning Bliddal

                            Country arrow
                            EPSC
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Intensive Weight Loss Diet,Inapplicable

                            Therapeutic Area : Rheumatology

                            Study Phase : Undisclosed

                            Sponsor : Oak Foundation | The Danish Rheumatism Association | Cambridge Weight Plan

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Weight Loss for Obese Individuals With Gout

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            September 10, 2018

                            Lead Product(s) : Intensive Weight Loss Diet,Inapplicable

                            Therapeutic Area : Rheumatology

                            Highest Development Status : Undisclosed

                            Sponsor : Oak Foundation | The Danish Rheumatism Association | Cambridge Weight Plan

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            Benha University

                            Country arrow
                            EPSC
                            Not Confirmed

                            Benha University

                            Country arrow
                            EPSC
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Febuxostat,Inapplicable

                            Therapeutic Area : Rheumatology

                            Study Phase : Undisclosed

                            Sponsor : New Jeddah Clinic Hospital

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Use of Febuxostat in Hyperuricemia Among Hemodialysis Patients

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Other Small Molecule

                            Upfront Cash : Inapplicable

                            May 11, 2017

                            Lead Product(s) : Febuxostat,Inapplicable

                            Therapeutic Area : Rheumatology

                            Highest Development Status : Undisclosed

                            Sponsor : New Jeddah Clinic Hospital

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            05

                            Hiroshima University

                            Country arrow
                            EPSC
                            Not Confirmed

                            Hiroshima University

                            Country arrow
                            EPSC
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Chrysanthemum Flower Oil,Inapplicable

                            Therapeutic Area : Rheumatology

                            Study Phase : Undisclosed

                            Sponsor : Kaneka Corporation

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effect of Chrysanthemum Flower Oil and Its Dose-dependency on Hyperuricemia

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            August 11, 2014

                            Lead Product(s) : Chrysanthemum Flower Oil,Inapplicable

                            Therapeutic Area : Rheumatology

                            Highest Development Status : Undisclosed

                            Sponsor : Kaneka Corporation

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            06

                            Freed Study Group

                            Country arrow
                            EPSC
                            Not Confirmed

                            Freed Study Group

                            Country arrow
                            EPSC
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Febuxostat,Inapplicable

                            Therapeutic Area : Rheumatology

                            Study Phase : Undisclosed

                            Sponsor : Teijin Pharma

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Febuxostat for Cerebral and caRdiorenovascular Events prEvEntion stuDy

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Other Small Molecule

                            Upfront Cash : Inapplicable

                            November 15, 2013

                            Lead Product(s) : Febuxostat,Inapplicable

                            Therapeutic Area : Rheumatology

                            Highest Development Status : Undisclosed

                            Sponsor : Teijin Pharma

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            07

                            Columbia Orthopaedic Group, LLP

                            Country arrow
                            EPSC
                            Not Confirmed

                            Columbia Orthopaedic Group, LLP

                            Country arrow
                            EPSC
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Plasma,Inapplicable

                            Therapeutic Area : Rheumatology

                            Study Phase : Undisclosed

                            Sponsor : Inapplicable

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            ACP for Local Application in Ankle Arthrodesis

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            May 27, 2010

                            Lead Product(s) : Plasma,Inapplicable

                            Therapeutic Area : Rheumatology

                            Highest Development Status : Undisclosed

                            Sponsor : Inapplicable

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth